← Back to Patent Explorer
US4826675A Expired / Lapsed US ⏱️ 0.0 years remaining

Anticalculus oral composition

Assignee: Colgate Palmolive Co
•
Filing: 1988-02-17
•
Granted: 1989-05-02
•
Expires: 2008-02-17
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An Anticalculus Oral Composition, typically a mouthwash or dentifrice gel, containing compound having C-O-P bonds, such as phytic acid or an alkali metal (including ammonium) salt thereof as anticalculus agent, homogeneously distributed in a dentally acceptable oral vehicle. Also, present to inhibit enzymatic hydrolysis of the phytic compound and to promote caries reduction is an alkali metal fluoride.

Inventors

  • 👤 Abdul Gaffar
  • 👤 Shek-Hong Lau
  • 👤 John Afflitto

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 19:52
CPC Classifications
A; A61; A61Q; A61Q11/00; A61K; A61K8/00; A61K8/18; A61K8/19; A61K8/20; A61K8/21; A61K8/30; A61K8/55

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 113 words
An anticalculus oral composition consisting essentially of a dentally acceptable oral vehicle and homogeneously distributed therein about 0.1-7% by weight of a compound having C--O--P bonds selected from the group consisting of phytic acid, myo-inositol tetrakis dihydrogen phosphate, myo-inositol trikis dihydrogen phosphate, phosphoglyceric acid, phosphoenol pyruvic acid and alkali metal salt thereof as inhibitor of hydroxyapatite formation and about 0.02-2.2% by weight of an alkali metal fluoride as inhibitor of enzymatic hydrolysis and also anti-caries agent, said alkali metal fluoride being the sole anti-caries agent which provides fluoride to the oral composition, said oral composition containing no compounds which provide polyvalent cations capable of forming a complex with said inhibitor of hydroxyapatite formation.
Claim 2
Dependent Claim 113 words
An anticalculus oral composition consisting essentially of a dentally acceptable oral vehicle and homogeneously distributed therein about 0.1-7% by weight of a compound having C--O--P bonds selected from the group consisting of phytic acid, myo-inositol tetrakis dihydrogen phosphate, myo-inositol trikis dihydrogen phosphate, phosphoglyceric acid, phosphoenol pyruvic acid and alkali metal salt thereof as inhibitor of hydroxyapatite formation and about 0.02-2.2% by weight of an alkali metal fluoride as inhibitor of enzymatic hydrolysis and also anti-caries agent, said alkali metal fluoride being the sole anti-caries agent which provides fluoride to the oral composition, said oral composition containing no compounds which provide polyvalent cations capable of forming a complex with said inhibitor of hydroxyapatite formation.
Claim 3
Dependent Claim 23 words
The anticalculus oral composition claimed in claim 1 wherein said compound having C--O--P bonds is phytic acid or an alkali metal salt thereof.
Claim 4
Dependent Claim 16 words
The anticalculus oral composition claimed in claim 1 wherein said alkali metal fluoride is sodium fluoride.
Claim 5
Dependent Claim 16 words
The anticalculus oral composition claimed in claim 2 wherein said alkali metal fluoride is sodium fluoride.
Claim 6
Dependent Claim 36 words
The anticalculus oral composition claimed in claim 1 wherein said dentally acceptable oral vehicle contains water and humectant collectively in amount of about 10-90% by weight and about 5-50% by weight of a siliceous polishing agent.
Claim 7
Dependent Claim 30 words
The anticalculus oral composition claimed in claim 5 wherein said compound having C--O--P bonds is phytic acid or the sodium salt thereof and said alkali metal fluoride is sodium fluoride.
Claim 8
Dependent Claim 39 words
The anticalculus oral composition claimed in claim 1 wherein said dentally acceptable oral vehicle contains about 70-99.99% by weight of water-non-toxic alcohol mixture and the weight ratio of water to non-toxic alcohol is from about 1:1 to about 20:1.
Claim 9
Dependent Claim 36 words
The anticalculus oral composition claimed in claim 7 wherein said compound having C--O--P bonds is phytic acid or the sodium salt thereof, said alkali metal fluoride is sodium fluoride and said non-toxic alcohol is ethyl alcohol.
Claim 10
Independent Claim 133 words
A method of inhibiting dental calculus comprising applying to teeth a calculus-inhibiting amount of an anticalculus oral composition having a pH of about 4.5 to about 9 consisting essentially of a dentally acceptable oral vehicle and homogeneously distributed therein about 0.1-7% by weight of a compound having C--O--P bonds selected from the group consisting of phytic acid myo-inositol tetrakis (dihydrogen phosphate), myo-inositol trikis (dihydrogen phosphate), phosphoglyceric acid, phosphenol pyruvic acid and alkali metal salt thereof as inhibitor of enzymatic hydrolysis and also anti-caries agent, said alkali metal fluoride being the sole anti-caries agent which provides fluoride to the oral composition, said oral composition containing no compounds which provide polyvalent cations capable of forming a complex with said inhibitor of hydroxyapatite formation, said composition when being so applied being effective to inhibit dental calculus.
Claim 11
Independent Claim 133 words
A method of inhibiting dental calculus comprising applying to teeth a calculus-inhibiting amount of an anticalculus oral composition having a pH of about 4.5 to about 9 consisting essentially of a dentally acceptable oral vehicle and homogeneously distributed therein about 0.1-7% by weight of a compound having C--O--P bonds selected from the group consisting of phytic acid myo-inositol tetrakis (dihydrogen phosphate), myo-inositol trikis (dihydrogen phosphate), phosphoglyceric acid, phosphenol pyruvic acid and alkali metal salt thereof as inhibitor of enzymatic hydrolysis and also anti-caries agent, said alkali metal fluoride being the sole anti-caries agent which provides fluoride to the oral composition, said oral composition containing no compounds which provide polyvalent cations capable of forming a complex with said inhibitor of hydroxyapatite formation, said composition when being so applied being effective to inhibit dental calculus.

References Cited (Backward Citations)

US3934002A Cited
US4263276A Cited
US4305928A Cited
US4259316A Cited
US4335102A Cited
US4528181A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-05-01 1992-10-31 1993-05-02 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-05-01 1996-10-31 1997-05-02 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-05-01 2000-10-31 2001-05-02 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag